Cancer-causing mutations can also activate the proteasome, so drugs that block protein breakdown, such as nelfinavir, could theoretically halt both diseases.

• 变异的癌症细胞也可以激活蛋白酶体，像那非那韦之类阻断蛋白分解的药物，理论上可以治疗癌症。